Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype
Abroad (travel likely)RecruitingPHASE2
Conditions
Richter Syndrome · Diffuse Large B-Cell Lymphoma · Chronic Lymphocytic Leukemia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Roswell Park Cancer Institute, Buffalo, New York, United States
Contact: Principal Investigator (Matthew J. Cortese)
Study leads
Matthew J Cortese
Principal Investigator
Roswell Park Cancer Institute